U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976697) titled 'Home-Based tDCS Treatment Of Major Depressive Disorder' on May 07.
Brief Summary: The REACH-tDCS study will evaluate the safety and efficacy of a noninvasive, at-home self-administered Sooma tDCS brain stimulation treatment for Major Depressive Disorder. The study uses randomized, blinded, placebo controlled design. The participants are assessed with video interviews and self-reports during the study, which lasts for 10 weeks followed by an optional continuation period.
Study Start Date: May 15
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder (MDD)
Intervention:
DEVICE: Transcranial direct current stimulation
In...